182 related articles for article (PubMed ID: 25789686)
1. Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease.
Yandrapu H; Marcinkiewicz M; Poplawski C; Han K; Zbroch T; Goldin G; Sarosiek I; Namiot Z; Sarosiek J
Am J Med Sci; 2015 May; 349(5):385-91. PubMed ID: 25789686
[TBL] [Abstract][Full Text] [Related]
2. A distinct salivary secretory response mediated by the esophago-salivary reflex in patients with Barrett's esophagus: its potential pathogenetic implications.
Yandrapu H; Marcinkiewicz M; Poplawski C; Namiot Z; Zbroch T; Sarosiek J
Adv Med Sci; 2014 Sep; 59(2):281-7. PubMed ID: 25181642
[TBL] [Abstract][Full Text] [Related]
3. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis.
Rourk RM; Namiot Z; Sarosiek J; Yu Z; McCallum RW
Am J Gastroenterol; 1994 Feb; 89(2):237-44. PubMed ID: 8304310
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease.
Sarosiek J; Scheurich CJ; Marcinkiewicz M; McCallum RW
Gastroenterology; 1996 Mar; 110(3):675-81. PubMed ID: 8608875
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effect of esophageal intraluminal mechanical and chemical stressors on salivary prostaglandin E2 in humans.
Namiot Z; Yu ZJ; Piascik R; Hetzel DP; McCallum RW; Sarosiek J
Am J Med Sci; 1997 Feb; 313(2):90-8. PubMed ID: 9030674
[TBL] [Abstract][Full Text] [Related]
6. The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease.
Marcinkiewicz M; Han K; Zbroch T; Poplawski C; Gramley W; Goldin G; Sarosiek J
Am J Gastroenterol; 2000 Jul; 95(7):1652-60. PubMed ID: 10925964
[TBL] [Abstract][Full Text] [Related]
7. Effect of esophageal intraluminal mechanical and chemical stressors on salivary epidermal growth factor in humans.
Li L; Yu Z; Piascik R; Hetzel DP; Rourk RM; Namiot Z; Sarosiek J; McCallum RW
Am J Gastroenterol; 1993 Oct; 88(10):1749-55. PubMed ID: 8213719
[TBL] [Abstract][Full Text] [Related]
8. Do salivary organic components play a protective role in health and disease of the esophageal mucosa?
Sarosiek J; McCallum RW
Digestion; 1995; 56 Suppl 1():32-7. PubMed ID: 7556968
[TBL] [Abstract][Full Text] [Related]
9. Differences in salivary secretion and epidermal growth factor concentrations in mild reflux esophagitis and non-erosive reflux disease.
Koeda M; Momma E; Tanabe T; Kitasako Y; Hoshikawa Y; Hoshino S; Kawami N; Iwakiri K
Esophagus; 2023 Apr; 20(2):317-324. PubMed ID: 36344779
[TBL] [Abstract][Full Text] [Related]
10. Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect.
Majewski M; Jaworski T; Sarosiek I; Sostarich S; Roeser K; Edlavitch SA; Kralstein J; Wallner G; McCallum RW; Sarosiek J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):430-8. PubMed ID: 17445751
[TBL] [Abstract][Full Text] [Related]
11. Esophagoprotective potential of cisapride. An additional benefit for gastroesophageal reflux disease.
Goldin GF; Marcinkiewicz M; Zbroch T; Bityutskiy LP; McCallum RW; Sarosiek J
Dig Dis Sci; 1997 Jul; 42(7):1362-9. PubMed ID: 9246029
[TBL] [Abstract][Full Text] [Related]
12. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.
Hershcovici T; Jha LK; Fass R
J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040
[TBL] [Abstract][Full Text] [Related]
13. Saliva secretion is reduced in proton pump inhibitor-responsive non-erosive reflux disease patients.
Koeda M; Tanabe T; Kitasako Y; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Kaise M; Iwakiri K
Esophagus; 2021 Oct; 18(4):900-907. PubMed ID: 33886014
[TBL] [Abstract][Full Text] [Related]
14. Differences in salivary secretory function between patients with erosive esophagitis and those with nonerosive reflux disease.
Manabe N; Haruma K; Kusunoki H; Kamada T; Hata J
J Gastroenterol Hepatol; 2018 Apr; 33(4):807-813. PubMed ID: 28960499
[TBL] [Abstract][Full Text] [Related]
15. Salivary bicarbonate as a major factor in the prevention of upper esophageal mucosal injury in gastroesophageal reflux disease.
Skoczylas T; Yandrapu H; Poplawski C; Asadi M; Wallner G; Sarosiek J
Dig Dis Sci; 2014 Oct; 59(10):2411-6. PubMed ID: 24610537
[TBL] [Abstract][Full Text] [Related]
16. Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis.
Rourk RM; Namiot Z; Edmunds MC; Sarosiek J; Yu Z; McCallum RW
Am J Gastroenterol; 1994 Aug; 89(8):1177-84. PubMed ID: 8053431
[TBL] [Abstract][Full Text] [Related]
17. Salivary epidermal growth factor concentrations in patients with Sjögren syndrome and laryngopharyngeal reflux.
Eckley CA; Dos Anjos Corvo MA; Sardinha LR; Liquidato B; Rizzo LV
Ear Nose Throat J; 2017 Jun; 96(6):E6-E11. PubMed ID: 28636735
[TBL] [Abstract][Full Text] [Related]
18. Does the healing of the esophageal mucosa improve the function of the esophageal submucosal and salivary glands?
Sarosiek J
Ann N Y Acad Sci; 2016 Sep; 1380(1):155-161. PubMed ID: 27532891
[TBL] [Abstract][Full Text] [Related]
19. Acid sensitization of esophageal mucosal afferents: implication for symptom perception in patients across the gastroesophageal reflux disease spectrum.
Szczesniak MM; Fuentealba SE; Cook IJ
Clin J Pain; 2013 Jan; 29(1):70-7. PubMed ID: 22330131
[TBL] [Abstract][Full Text] [Related]
20. Increased esophageal sensitivity to acid and saline in patients with nonerosive gastro-esophageal reflux disease.
Nagahara A; Miwa H; Minoo T; Hojo M; Kawabe M; Osada T; Kurosawa A; Asaoka D; Terai T; Ohkusa T; Sato N
J Clin Gastroenterol; 2006; 40(10):891-5. PubMed ID: 17063106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]